Maximizing Treatment Options for IBD through Drug Repurposing.

Autor: Barjasteh AH; Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Al-Asady AM; Department of Medical Sciences, Faculty of Nursing, Warith Al-Anbiyaa University, Karbala, Iraq.; Department of Medical Sciences, Faculty of Dentistry, University of Kerbala, Karbala, Iraq.; Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Latifi H; Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Al Okla S; College of Medicine and Health Sciences, National University of Science and Technology, Muscat, Oman.; Department of Animal Biology, Faculty of Sciences, Damascus University, Damascus, Syria., Al-Nazwani N; Department of Biochemistry, College of Medicine and Health Sciences, National University of Science and Technology, Sohar, Oman., Avan A; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran., Khazaei M; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.; Department of Medical Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Ryzhikov M; School of Medicine, Saint Louis University, St. Louis, MO 63103, USA., Nadi-Yazdi H; Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Hassanian SM; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.; Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Publikováno v: Current pharmaceutical design [Curr Pharm Des] 2024; Vol. 30 (32), pp. 2538-2549.